As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom announced Oct. 16 that CalRx® ...

EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Nido, short for Neat Insulin Daily Organiser, makes insulin injections safer and more convenient for persons with diabetes.

For many elderly diabetics, daily insulin injections become harder to manage with age-related cognitive decline. Missed doses ...

California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.

California Gov. Gavin Newsom (D) announced Thursday that cheaper, state-made insulin for diabetics, an endeavor he unveiled more than three years ago, is set to hit shelves in January. A five-pack of ...

The pens are part of an initiative to “fundamentally lower health care costs, not spread” them, Gov. Gavin Newsom said.

Californians with diabetes will soon have access to a low-cost insulin pen as part of a new state initiative announced today, October 16, by Gov. Gavin Newsom.Beginning Jan. 1, 2026, CalRx-branded ...

Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a Cedars-Sinai pharmacy in Los Angeles on Thursday. The effort is part of ...

California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a ...

California Gov. Gavin Newsom on Thursday announced a plan to offer $11 insulin pens through the state's pharmaceutical venture. Beginning Jan. 1, consumers can purchase a five-pack of pens for a ...